Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.
Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.
Fintel reports that on November 11, 2025, Wells Fargo maintained coverage of Keros Therapeutics (NasdaqGM:KROS) with a ...
Investor's Business Daily on MSN
Keros Therapeutics Earns Relative Strength Rating Upgrade
A Relative Strength Rating upgrade for Keros Therapeutics shows improving technical performance. Will it continue?
Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...
But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the best way to discover great value opportunities is to pair a ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...
Keros Therapeutics, Inc. ( NASDAQ:KROS ) defied analyst predictions to release its quarterly results, which were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback